SCHEMBL5503063

SCHEMBL5503063

CC(C)(C)c1ccc(CNC(=O)NCc2cc(F)c(NS(=O)(=O)CNS(C)(=O)=O)c(I)c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2000614 0.90 TRPV1 (0.56) TRPV1
Methanesulfonamide SCHEMBL5503061 0.87 TRPV1 (0.53) TRPV1
SCHEMBL1998884 0.82 TRPV1 (0.61) TRPV1
SCHEMBL2000369 0.79 TRPV1 (0.58) TRPV1
SCHEMBL2003817 0.78 TRPV1 (0.56) TRPV1
SCHEMBL2952151 0.76 EPHX2 (0.49) TRPV1
SCHEMBL2948751 0.75 TRPV1 (0.53) TRPV1
SCHEMBL2006323 0.75 TRPV1 (0.53) TRPV1
SCHEMBL2004075 0.75
SCHEMBL2004076 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1861358-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2007-12-05 EP disclosed
WO-2006101321-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2006-09-28 WO disclosed